SFM
CHRS icon

Soros Fund Management’s Coherus Oncology CHRS Stock Holding History

Soros Fund Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-127,600
Closed -$2.93M – 243
2015
Q4 		$2.93M Hold
127,600
– – 0.05% 142
2015
Q3 		$2.56M Hold
127,600
– – 0.04% 171
2015
Q2 		$3.69M Buy
+127,600
New +$3.23M 0.03% 186

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Soros Fund Management's CHRS Position: Q1 2016 in Review

Soros Fund Management sold out of Coherus Oncology (CHRS) in Q1 2016, closing a stake of 127,600 shares — an estimated $2.93M sold.

Soros Fund Management first reported a position in CHRS in Q2 2015 and held it in 3 quarters. The position peaked at $3.69M in Q2 2015. 75 funds tracked by Wall St. Rank hold CHRS as of Q1 2016.

  • Soros Fund Management reported no remaining Coherus Oncology position as of Q1 2016 after selling out during the quarter.
  • Soros Fund Management sold 127,600 Coherus Oncology shares in Q1 2016, an estimated $2.93M.
  • Soros Fund Management first reported a position in Coherus Oncology in Q2 2015 and held it in 3 quarters.
  • Soros Fund Management's Coherus Oncology position peaked at $3.69M in Q2 2015.
  • 75 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2016.

Based on Soros Fund Management's 13F filing for Q1 2016, filed 16 May 2016.